Topic Archives: Danaher (DHR)

We’ve written a lot about the trend toward pitching genomics and DNA sequencing as the “next big thing” — most of the big newsletter publishers have some kind of spiel out that focuses on the huge growth in genomics, staking out their big winners in this space… and Charles Mizrahi is the latest, with a […]

Comments

  • Regarding the below 'wannabets' comment. Danaher is DHR. Currently trading at $249.19 on NYSE. Diamond Rock H...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info